Ferring’s Fecal Transplant Gets Through AdComm, Aided By Preference For Standardized Product

 
• By Sarah Karlin-Smith
How Rebyota might change the regulatory landscape for unapproved fecal transplants was among the advisory committee's considerations. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers